The SciLifeLab Director and European Lead Factory executives have signed a Memorandum of Understanding for collaboration in future initiatives.
SciLifeLab and the EU Lead Factory, a collaborative public-private partnership aiming to deliver innovative drug discovery starting points by e.g. giving free access to up to 500,000 novel compounds, declare to exploit the complementarity and synergistic potential between their activities. For example, the assay development and early drug discovery expertise at SciLifeLab complements the high-capacity screening capability of the EU Lead Factory.
Both parties believe cooperation in the framework of future European programmes may be mutually beneficial, especially given the common stakeholder communities involved and the overlap in terms of potential users.
The EU Lead Factory is an open innovation platform for drug discovery, funded under the EU Innovative Medicines Initiative (IMI) and managed by an international consortium of 30 partners. Those partners include seven members of the European Federation of Pharmaceutical Industries and Associations (EFPIA), as well as many different academic institutions and small and medium-sized enterprises.
Read more at the EU Lead Factor website